Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million - Seite 3
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) - Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary …